|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 |
| (11) | Patento numeris | 3024851 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14748461.2 |
| Europos patento paraiškos padavimo data | 2014-07-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-06-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-05-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/048289 |
| Data | 2014-07-25 |
| (87) | Numeris | WO 2015/013671 |
| Data | 2015-01-29 |
| (30) | Numeris | Data | Šalis |
| 201361858402 P | 2013-07-25 | US |
| (72) |
IRVING, Bryan Allen, US
HOSTETTER, Daniel Robert, US
WONG, Chihong, US
LOWMAN, Henry Bernard, US
WEST, James William, US
LA PORTE, Sherry Lynn, US
|
| (73) |
CytomX Therapeutics, Inc.,
151 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080,
US
|
| (54) | MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USING THE SAME |
| MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USING THE SAME |